BR112015028884A2 - tratamento ou prevenção de depressão utilizando mentol e/ou icilina - Google Patents
tratamento ou prevenção de depressão utilizando mentol e/ou icilinaInfo
- Publication number
- BR112015028884A2 BR112015028884A2 BR112015028884A BR112015028884A BR112015028884A2 BR 112015028884 A2 BR112015028884 A2 BR 112015028884A2 BR 112015028884 A BR112015028884 A BR 112015028884A BR 112015028884 A BR112015028884 A BR 112015028884A BR 112015028884 A2 BR112015028884 A2 BR 112015028884A2
- Authority
- BR
- Brazil
- Prior art keywords
- iciline
- menthol
- treating
- preventing depression
- depression
- Prior art date
Links
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 title abstract 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title abstract 3
- 229940041616 menthol Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/08—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a six-membered rings
- C07C35/12—Menthol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361827256P | 2013-05-24 | 2013-05-24 | |
| PCT/EP2014/060634 WO2014187943A1 (en) | 2013-05-24 | 2014-05-23 | Treatment or prevention of depression using menthol and/or icilin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015028884A2 true BR112015028884A2 (pt) | 2017-07-25 |
Family
ID=50841770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015028884A BR112015028884A2 (pt) | 2013-05-24 | 2014-05-23 | tratamento ou prevenção de depressão utilizando mentol e/ou icilina |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160108005A1 (enExample) |
| EP (1) | EP3003294A1 (enExample) |
| JP (1) | JP2016524609A (enExample) |
| CN (1) | CN105263481A (enExample) |
| AU (1) | AU2014270339A1 (enExample) |
| BR (1) | BR112015028884A2 (enExample) |
| CA (1) | CA2908378A1 (enExample) |
| WO (1) | WO2014187943A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116158550A (zh) * | 2022-12-19 | 2023-05-26 | 惠州市新泓威科技有限公司 | 具有抗抑郁作用的电子烟雾化液及其制备方法 |
| CN116076776A (zh) * | 2022-12-19 | 2023-05-09 | 惠州市新泓威科技有限公司 | 具有抑制单胺氧化酶活性作用的电子烟雾化液 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7897781B2 (en) * | 2006-05-10 | 2011-03-01 | Janssen Pharmaceutica Nv | Cold menthol receptor-1 antagonists |
| MY153971A (en) * | 2007-07-18 | 2015-04-30 | Janssen Pharmaceutica Nv | Sulfonamides as trpm8 modulators |
| US8217060B2 (en) * | 2009-05-15 | 2012-07-10 | Janssen Pharmaceutica, Nv | Benzimidazole derivatives useful as TRP M8 receptor modulators |
| EP3485881B1 (en) * | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| JP2012193176A (ja) * | 2011-03-03 | 2012-10-11 | Nippon Zoki Pharmaceut Co Ltd | ミルナシプラン含有経皮吸収用医薬組成物 |
| CN102258751A (zh) * | 2011-07-21 | 2011-11-30 | 泰一和浦（北京）中医药研究院有限公司 | 用于治疗忧郁症、消愁解忧、善解抑郁的中药薄荷 |
| JP5376481B1 (ja) * | 2013-03-04 | 2013-12-25 | 日本臓器製薬株式会社 | 経皮吸収用医薬組成物 |
-
2014
- 2014-05-23 AU AU2014270339A patent/AU2014270339A1/en not_active Abandoned
- 2014-05-23 US US14/892,016 patent/US20160108005A1/en not_active Abandoned
- 2014-05-23 WO PCT/EP2014/060634 patent/WO2014187943A1/en not_active Ceased
- 2014-05-23 CA CA2908378A patent/CA2908378A1/en not_active Abandoned
- 2014-05-23 JP JP2016514430A patent/JP2016524609A/ja not_active Withdrawn
- 2014-05-23 CN CN201480029644.1A patent/CN105263481A/zh active Pending
- 2014-05-23 EP EP14726946.8A patent/EP3003294A1/en not_active Withdrawn
- 2014-05-23 BR BR112015028884A patent/BR112015028884A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016524609A (ja) | 2016-08-18 |
| CN105263481A (zh) | 2016-01-20 |
| EP3003294A1 (en) | 2016-04-13 |
| US20160108005A1 (en) | 2016-04-21 |
| CA2908378A1 (en) | 2014-11-27 |
| AU2014270339A1 (en) | 2015-10-08 |
| WO2014187943A1 (en) | 2014-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017003658A2 (pt) | composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica. | |
| BR112015022462A8 (pt) | inibidores de ido, composição farmacêutica, método de inibição de atividade de indolamina 2,3-dioxigenase e uso dos referidos inibidores | |
| BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
| BR112016003201A2 (pt) | inibidores de grp94 seletivos e usos dos mesmos | |
| MX389242B (es) | Compuestos para su uso en el tratamiento de trastornos neuromusculares | |
| EA201692506A2 (ru) | Ингибиторы репликации вирусов гриппа | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| BR112015028879A8 (pt) | compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos | |
| BR112015022417A2 (pt) | métodos e composições para inibição de proteínas contendo bromodomínio | |
| EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
| BR112016014481A2 (pt) | tratamento de câncer utilizando combinações de inibidores de erk e raf | |
| BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
| MX2016011810A (es) | Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso. | |
| MX2016000295A (es) | Inhibidores de indoleamina 2,3-dioxigenasa (ido). | |
| BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
| BR112014019399A2 (pt) | métodos de tratamento da fibrose | |
| BR112015028516A2 (pt) | tratamento ou prevenção de distúrbios neurodegenerativos com o uso de mentol, linalol e/ou icilina | |
| EA201591180A1 (ru) | Составы ингибитора lfa-1 | |
| BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
| BR112017026535A2 (pt) | composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto | |
| BR112016007462A2 (pt) | fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
| BR112016016098A2 (pt) | Compostos orgânicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |